Abstract
PURPOSE: Treatment of perianal condyloma acuminata is frustrating because most treatment options are fraught with high recurrence rates and patient discomfort. We propose that surgical excision followed by vaccination with an autogenous condyloma acuminata vaccine is the most effective therapy available in primary and recurrent perianal condyloma acuminata. METHODS: Eighty-three patients with perianal condyloma acuminata were treated from 1985 to 1992. Treatment was divided for patients as follows: surgical excision, 20; bichloroacetic acid, 10; podophyllin and interferon A, 5; excision followed by autogenous condyloma acuminata vaccination twice weekly using 0.1 ml subcutaneously for three weeks increasing to 1.0 ml subcutaneously for seven weeks, 43. Syphilis was diagnosed in seven patients; two were human immunovirus-positive. All but three patients were male. Of those patients treated with the vaccination protocol, 25 had primary and 18 had recurrent disease. RESULTS: Recurrence rates were: excision alone and bichloroacetic acid, 50 percent; podophyllin and interferon A, 85 percent; whereas only 4.6 percent recurred when treated with excision and vaccination. Mean follow-up was 13 (range, 6–23) months. All patients treated with the vaccination protocol tolerated the full course of therapy. CONCLUSION: We believe that excision of perianal condyloma acuminata followed by autogenous condyloma acuminata vaccination for approximately ten weeks is the most effective and definitive treatment option and, moreover, should be considered in all patients with perianal condyloma acuminata.
Similar content being viewed by others
References
Swerdlow DB, Salvati EP. Condyloma acuminata. Dis Colon Rectum 1971;14:226–31.
Thompson JP, Grace RH. The treatment of perianal and anal condyloma acuminata: a new operative technique. J R Soc Med 1978;71:180–5.
Abcarian H, Sharon N. Long term effectiveness of the immunotherapy of anal condyloma acuminata. Dis Colon Rectum 1982;25:648–51.
Biberstein H. Immunization therapy of warts. Arch Dermatol 1944;50:12–22.
Powell LC Jr, Pollard M, Jinkins JL Sr. Treatment of condyloma acuminata by autogenous vaccine. South Med J 1970;63:202–5.
Nel WS, Fourie ED. Immunotherapy and 5 percent topical 5-flourouracil ointment in the treatment of condyloma acuminata. S Afr Med J 1073;47:45–9.
Eftaiha MS, Amshel AL, Shonberg IL, Batshon B. Giant and recurrent condyloma acuminata: appraisal of immunotherapy. Dis Colon Rectum 1982;25:136–8.
Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984;27:763–6.
Sohn N, Robilotti JG Jr. The gay bowel syndrome: a review of colonic and rectal conditions in 200 male homosexuals. Am J Gastroenterol 1977;67:478–84.
Corman ML. Colon and rectal surgery. Philadelphia: JB Lippincott, 1993.
Abcarian H, Smith D, Sharon N. The immunotherapy of anal condyloma acuminatum. Dis Colon Rectum 1976;19:237–44.
Abcarian H, Sharon N. The effectiveness of immunotherapy in the treatment of anal condyloma acuminatum. J Surg Res 1977;22:231–6.
Ablin RJ, Curtis WW. Immunotherapeutic treatment of condyloma acuminata. Gynecol Oncol 1974;2:446–50.
Blair JF, Lemmette EH. Manual of clinical microbiology. Bethesda: Williams & Wilkins, 1970.
Zinsser L, Bayne-Jones J. Textbook of biochemistry. New York: Appleton-Century, 1928.
Beckmann AM, Daling JR, Sherman KJ,et al. Human papillomavirus infection and anal cancer. Int J Cancer 1989;43:1042–9.
Author information
Authors and Affiliations
Additional information
Read at the meeting of The American Society of Colon and Rectal Surgeons, Orlando, Florida, May 8 to 13, 1994.
About this article
Cite this article
Wiltz, O.H., Torregrosa, M. & Wiltz, O. Autogenous vaccine: The best therapy for perianal condyloma acuminata?. Dis Colon Rectum 38, 838–841 (1995). https://doi.org/10.1007/BF02049840
Issue Date:
DOI: https://doi.org/10.1007/BF02049840